Abstract 86 Table 1

Differences in HRV

AF + hypertension group(n = 40)Hypertension control group(n = 20)p
Clinical DemographicsMean ± SD / Median [IQR] Mean ± SD / Median [IQR]
Age, years66 ± 765 ± 70.71
SexMaleFemale 2911 155 0.84
BMI (kg/m2)32.9 ± 5.232.1 ± 4.20.58
HRV Measurements Mean [95% CI] / Median [95% CI] Mean [95% CI] / Median [95% CI] p
Heart rate66 [61 – 72]a 60 [56 – 66]a 0.12
SDNN (ms)62 [48 – 80]a 33 [27 – 41]a <0.001
rMSSD (ms)97 [35 – 105]b 26 [20 – 37]b 0.002
pNN50 (%)58 [25 – 64]b 5 [1 – 17]b <0.001
LF normalised (%)42 [33 – 52]a* 48 [38 – 58]a 0.39
HF normalised (%)58 [48 – 67]a* 52 [42 – 62]a 0.39
LF-i/HF-i0.7 [0.5 – 1.1]a* 0.8 [0.6 – 1.2]a 0.61
SD1 (ms)65 [38 – 74]b 18 [14 – 26]b <0.001
SD2 (ms)90 [72 – 108]a 47 [36 – 58]a <0.001
SD1/SD20.7 [0.6 – 0.7]a 0.5 [0.4 – 0.5]a 0.002
  • Normally distributed data are expressed as mean ± standard deviation for descriptive data and mean [95%confidence interval (CI)] otherwise. Identified bysuperscript a. Non-normally distributed data are displayed as median withinterquartile ranges for descriptive data and median [95% CI] otherwise.Identified by superscript b. Normality test was performed using Shapiro-Wilktest. Statistical differences were tested usingindependent t-test (for parametric data) or Mann-Whitney U test (fornon-parametric data). Significance p ≥ 0.05.